HilleVax, Inc. — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$147.3M

Total Assets (FY2024)

$192.7M

Total Equity (FY2024)

$154.5M

Cash Flows from Operating Activities (FY2024)

-$108.8M

Source: HilleVax, Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.